Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Targeted Proteomics Identifies Paraoxonase/Arylesterase 1 (PON1) and Apolipoprotein Cs as Potential Risk Factors for Hypoalphalipoproteinemia in Diabetic Subjects Treated with Fenofibrate and Rosiglitazone
Authors
Keywords
-
Journal
MOLECULAR & CELLULAR PROTEOMICS
Volume 15, Issue 3, Pages 1083-1093
Publisher
American Society for Biochemistry & Molecular Biology (ASBMB)
Online
2015-12-15
DOI
10.1074/mcp.m115.054528
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Parallel reaction monitoring (PRM) and selected reaction monitoring (SRM) exhibit comparable linearity, dynamic range and precision for targeted quantitative HDL proteomics
- (2015) Graziella E. Ronsein et al. Journal of Proteomics
- Recent advances in targeted proteomics for clinical applications
- (2015) Bruno Domon et al. Proteomics Clinical Applications
- Targeted Peptide Measurements in Biology and Medicine: Best Practices for Mass Spectrometry-based Assay Development Using a Fit-for-Purpose Approach
- (2014) Steven A. Carr et al. MOLECULAR & CELLULAR PROTEOMICS
- Loss-of-Function Mutations in APOC3, Triglycerides, and Coronary Disease
- (2014) NEW ENGLAND JOURNAL OF MEDICINE
- Paradoxical Reduction in HDL-C With Fenofibrate and Thiazolidinedione Therapy in Type 2 Diabetes: The ACCORD Lipid Trial
- (2013) Peter E. Linz et al. DIABETES CARE
- Proteomic diversity of high density lipoproteins: our emerging understanding of its importance in lipid transport and beyond
- (2013) Amy S. Shah et al. JOURNAL OF LIPID RESEARCH
- Technical considerations for large-scale parallel reaction monitoring analysis
- (2013) Sebastien Gallien et al. Journal of Proteomics
- Multi-dimensional Co-separation Analysis Reveals Protein–Protein Interactions Defining Plasma Lipoprotein Subspecies
- (2013) Scott M. Gordon et al. MOLECULAR & CELLULAR PROTEOMICS
- Multiple-Reaction Monitoring-Mass Spectrometric Assays Can Accurately Measure the Relative Protein Abundance in Complex Mixtures
- (2012) A. N. Hoofnagle et al. CLINICAL CHEMISTRY
- Selectivity of LC-MS/MS analysis: Implication for proteomics experiments
- (2012) Sebastien Gallien et al. Journal of Proteomics
- Targeted Proteomic Quantification on Quadrupole-Orbitrap Mass Spectrometer
- (2012) Sebastien Gallien et al. MOLECULAR & CELLULAR PROTEOMICS
- Parallel Reaction Monitoring for High Resolution and High Mass Accuracy Quantitative, Targeted Proteomics
- (2012) Amelia C. Peterson et al. MOLECULAR & CELLULAR PROTEOMICS
- Selected reaction monitoring–based proteomics: workflows, potential, pitfalls and future directions
- (2012) Paola Picotti et al. NATURE METHODS
- Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry
- (2012) Michael A Gillette et al. NATURE METHODS
- Change in High-Density Lipoprotein Cholesterol and Risk of Subsequent Hospitalization for Coronary Artery Disease or Stroke Among Patients With Type 2 Diabetes Mellitus
- (2011) Gregory A. Nichols et al. AMERICAN JOURNAL OF CARDIOLOGY
- Triglyceride-rich lipoproteins and high-density lipoprotein cholesterol in patients at high risk of cardiovascular disease: evidence and guidance for management
- (2011) M. John Chapman et al. EUROPEAN HEART JOURNAL
- A targeted proteomics–based pipeline for verification of biomarkers in plasma
- (2011) Jeffrey R Whiteaker et al. NATURE BIOTECHNOLOGY
- Apolipoprotein A-I structural organization in high-density lipoproteins isolated from human plasma
- (2011) Rong Huang et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Skyline: an open source document editor for creating and analyzing targeted proteomics experiments
- (2010) Brendan MacLean et al. BIOINFORMATICS
- Paradoxical Severe Decrease in High-Density Lipoprotein Cholesterol Due to Rosiglitazone-Fenofibrate Interaction
- (2010) William Schwing et al. Endocrine Practice
- Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus
- (2010) NEW ENGLAND JOURNAL OF MEDICINE
- Proteomic Analysis of Defined HDL Subpopulations Reveals Particle-Specific Protein Clusters
- (2009) W. Sean Davidson et al. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
- Iatrogenic Severe Depression of High-Density Lipoprotein Cholesterol
- (2009) D. Mymin et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Multi-site assessment of the precision and reproducibility of multiple reaction monitoring–based measurements of proteins in plasma
- (2009) Terri A Addona et al. NATURE BIOTECHNOLOGY
- Comprehensive evaluation of apolipoprotein H gene (APOH) variation identifies novel associations with measures of lipid metabolism in GENOA
- (2008) Magalie S. Leduc et al. JOURNAL OF LIPID RESEARCH
- Effect of fenofibrate therapy on paraoxonase1 status in patients with low HDL-C levels
- (2007) Wimon Phuntuwate et al. ATHEROSCLEROSIS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More